Skip to main content
Caplight Logo









EXIT071

EXIT071

Private
LeidenHealthcare & Life Scienceshttps://exit071.com/

Last Round

Seed

Mar 24, 2025

Total Funding Raised

$2.56M

Company Overview

EXIT071 B.V. is a biotechnology company that develops an integrated and automated platform for exosome isolation and molecular analysis for biomarker discovery, diagnostics, and therapeutic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

exosome isolationbiomarker discoveryliquid biopsymicrofluidicsextracellular vesiclesEV characterizationnon-invasive diagnosticslab-on-a-chipdepletion zone isotachophoresisdzITPlife science toolscontract research organizationCROexosome therapeuticsuniversity spin-out

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EXIT071 Comparables

Compare EXIT071 with similar companies based on industry and business-model similarity.

EXIT071 comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CellBio Scientific
78%
BioFluidica
76%
Izon Science
74%

EXIT071 Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 24, 2025
GrantMar 28, 2022
SeedFeb 15, 2022

Key People

Founding team and executive leadership

Andrea Capuano

Chief Technology Officer

Executive Team

EXIT071 Investors

Notable investors and investment history

EXIT071 investors
InvestorRounds
European Innovation Council FundGrant
Libertatis Ergo HoldingSeed

EXIT071 Filings

Explore SEC and related filing metadata, where available.

EXIT071 filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EXIT071's valuation, stock price, and market status.

Is EXIT071 a public or private company?

EXIT071 is a private company.

What is the current stock price of EXIT071?

EXIT071 is a private company with no public stock price. No recent secondary market data is available.

How much is EXIT071 worth (valuation)?

Valuation information for EXIT071 is not publicly available.

Can I buy EXIT071 stock?

EXIT071 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EXIT071's last funding round?

Funding round information for EXIT071 is not publicly available.

Who are the main investors in EXIT071?

Investor information for EXIT071 is not publicly disclosed.

Will EXIT071 IPO soon?

No public IPO plans have been announced for EXIT071.

How can I track EXIT071 secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EXIT071's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLeiden
Employee Range8
Year Founded2021
Last FundingMar 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?